Neuralink has made significant progress in developing its Telepathy and Blindsight products, with Musk revealing detailed updates on October 30. According to Neuralink's latest posts on X, the company's engineers recently conducted a 72-hour hackathon with a speech restoration study participant to rapidly prototype new features for thought-based communication. The Telepathy product, Neuralink's first offering, will enable high-speed communication with computers or humans simply by thinking, with output bandwidth expected to vastly exceed the fastest human speech or typing within a few years. Musk emphasized that brain-computer interfaces could eventually overcome the limitations of typing and speaking, potentially interpreting intended communication more directly than current translation methods.
Musk also revealed significant developments in Neuralink's Blindsight product, which is designed to restore vision for people with severe visual impairments. As reported by Neuralink, the technology would enable even those who are completely blind or have never seen to see, with the product ready from an engineering standpoint and awaiting regulatory approval. Blindsight operates as a visual prosthesis that aims to stimulate the brain's visual pathways, potentially allowing people with severe vision loss to perceive visual information. However, Musk's statement about engineering readiness should not be confused with regulatory clearance or proven clinical effectiveness, as the technology will need to demonstrate safety and efficacy through appropriate regulatory and clinical processes.
Despite these technological advancements, investment opportunities remain limited for most retail investors. As reported by BeInCrypto, Neuralink remains private and does not trade on any stock exchange, leaving few legitimate investment options. The ARK Venture Fund (ARKVX), run by ARK Invest, is the main regulated route for ordinary investors but is currently not available to international investors, pushing many retail investors outside the US toward higher-risk alternatives. The company's $9 billion valuation from its latest funding round explains the strong investor demand, though Neuralink's devices still lack FDA approval.
Several crypto products have emerged as unregulated alternatives, though they carry significant risks. According to BeInCrypto, Solana-based PreStocks lists a Neuralink token with a market cap of around $1 million, which jumped to a record high around the time of Musk's post before giving back part of the gains. The token's small size makes it vulnerable to sharp price movements from limited trading volume and potential manipulation. PreStocks claims its tokens are backed by exposure to company shares through special purpose vehicles, though this claim cannot be independently verified.
Neuralink continues to test its implants with participants in clinical studies, working to improve accuracy, reliability and speed of its brain-computer interfaces. The company's technology allows users to control a computer cursor by imagining movements of their hands, enabling tasks such as browsing the internet, writing messages, playing games and working on computers without physically using a mouse. This technology is particularly relevant for people with spinal cord injuries or certain neurological conditions who have lost mobility. While Neuralink's progress represents significant advancement in brain-computer interface technology, the gap between controlling a cursor through brain signals, communicating at speeds beyond human speech and restoring vision remains significant, with the company's progress depending on clinical results, safety, regulatory approvals and its ability to translate Musk's ambitious predictions into practical applications.
